Q2 2014 13F Holders as of 30 Jun 2014
-
Type / Class
-
Equity / Common Stock, $0.00000002 par value
-
Shares outstanding
-
29,545,622
-
Total 13F shares
-
13,292,012
-
Share change
-
-1,040,871
-
Total reported value
-
$84,269,801
-
Price per share
-
$6.34
-
Number of holders
-
40
-
Value change
-
-$14,971,805
-
Number of buys
-
17
-
Number of sells
-
30
Institutional Holders of MEI Pharma, Inc. - Common Stock, $0.00000002 par value (MEIP) as of Q2 2014
As of 30 Jun 2014,
MEI Pharma, Inc. - Common Stock, $0.00000002 par value (MEIP) was held by
40 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
13,292,012 shares.
The largest 10 holders included
FMR LLC, ORBIMED ADVISORS LLC, Visium Asset Management, LP, JPMORGAN CHASE & CO, FRANKLIN RESOURCES INC, DEERFIELD MANAGEMENT CO, Aisling Capital LLC, VANGUARD GROUP INC, SABBY MANAGEMENT, LLC, and Tekla Capital Management LLC.
This page lists
40
institutional shareholders reporting positions in this security
for the Q2 2014 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.